Urania Therapeutics
Strasbourg
About Urania Therapeutics
Urania Therapeutics company is developing a unique SBDD platform for the generation of new readthrough compounds with high potential in cancer and monogenic disorders.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $5.8M
- Funding stage: Seed
- Last round: Seed (Jan 2020)
- Website: uraniatx.com
Industries & Categories
Biotechnology, Pharmaceutical
Canonical: https://fsome.com/organization/urania-therapeutics-137038 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.